The Application segmentation of the Ophthalmic Ultrasound Systems market delineates four primary use‑cases that together shape total market revenue. Diagnostic applications, encompassing A‑scan biometry and B‑scan imaging for cataract, retinal detachment, and tumor assessment, dominate with roughly 55 % of sales, reflecting their entrenched role in routine ophthalmic examinations. Surgical applications, which integrate real‑time ultrasound guidance during procedures such as phacoemulsification and vitreoretinal surgery, account for about 30 % of the market, driven by the premium placed on intra‑operative precision. Screening uses, primarily in community‑based diabetic retinopathy and glaucoma programs, contribute near 10 % as portable units gain traction in low‑resource settings. Finally, Research applications—high‑resolution imaging for drug development and clinical trials—represent the remaining 5 %, supporting innovation pipelines. Collectively, these categories constitute the full Ophthalmic Ultrasound Systems segmentation landscape, each adding distinct value through volume, price point, and growth dynamics.